Assertion: small cell lung cancer | /r/HasProperty | nsclc
Facets:
Source sentences:
text: Non-small cell lung cancer (NSCLC
text: Non-small cell lung cancer (NSCLC)
text: There are two main types of lung cancer: Non-small cell lung cancer (NSCLC)
text: Non-small cell lung cancer (NSCLC)
text: What Is Non-Small-Cell Lung Cancer (NSCLC)?
text: Non-small cell lung cancer (NSCLC)
text: non small cell lung cancer (NSCLC) :
text: According to the American Cancer Society (ACS), non-small cell lung cancer (NSCLC) accounts for 80–85% of lung cancer cases.
text: Non-small cell lung cancer (NSCLC): About 80 to 85 percent of lung cancer cases
text: Non-small cell lung cancer (NSCLC)
text: There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC)
text: non small cell lung cancer (NSCLC)
text: Non small cell lung cancer (NSCLC)
text: non small cell lung cancer (NSCLC)
text: Non-small cell lung cancer (NSCLC)
text: non-small cell lung cancer (NSCLC):
text: Non-Small Cell Lung Cancer (NSCLC):
text: VISIT THESE WEBSITES FOR MORE INFORMATION ABOUT NON-SMALL CELL LUNG CANCER (NSCLC)
text: Non-small cell lung cancer (NSCLC)
text: Non-small cell lung cancer (NSCLC)
text: Non-small Cell Lung Cancer (NSCLC) represents 80% to 90% of all lung cancer cases each year.
text: The most common type is non-small cell lung cancer (NSCLC).
text: Treatment for non-small cell lung cancer (NSCLC) varies from person to person.
text: Options for small cell-lung cancer (NSCLC) also include surgery, chemotherapy, and radiation therapy.
text: In recent years, new treatments have been approved for stage 4 non-small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC) is a more common type of lung cancer than small cell.
text: These tumors are more likely to be non-small cell lung cancer (NSCLC) than small cell lung cancer (SCLC).
text: Nearly 9 out of 10 people with lung cancer have non-small cell-lung cancer (NSCLC).
text: Lung cancers are broadly classified into two types: small cell lung cancers (SCLC) and non-small cell lung cancers (NSCLC).
text: Some 85% of lung cancers are non-small-cell lung cancers (NSCLC).
text: Lung cancer overview The two main types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
text: There are two main types of lung cancer: non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).
text: Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 80 to 85 percent of all cases, according to the American Cancer Society.
text: There are two major types of lung cancer: small cell lung cancer (SCLC) and non–small cell lung cancer (NSCLC).
text: Small cell lung cancer (SCLC) is staged differently than non-small cell lung cancer (NSCLC), using this two-stage system: Limited stage: Cancer is found on only one side of your chest.
text: Doctors thought for a long time that immunotherapy wouldn’t work for non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), the two most common types.
text: Most lung cancer statistics include both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC), which occurs in 85%– 90% of all cases
text: Non-small-cell lung cancer (NSCLC) tends to grow more slowly and takes longer to spread beyond the lung.
text: According to the American Cancer Society, about 80 to 85 percent of lung cancers are non-small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.
text: Lung cancers are generally classified as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC).
text: Survivors of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) can get any type of second cancer, but they have an increased risk of:
text: The two main types of lung cancer, non-small-cell lung cancer (NSCLC) and small-cell lung cancer, are staged differently.
text: Non–small cell lung cancer (NSCLC) represents 80% to 90% of all lung cancer cases each year.
text: non-small cell lung cancer (NSCLC), the more common type of lung cancer that grows more slowly.
text: The two major types of lung cancer are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: There are two main types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: It is classified as one of several non-small cell lung cancers (NSCLC), to distinguish it from small cell lung cancer which has a different behavior and prognosis.
text: The majority of lung cancers can be characterized as either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC).
text: There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and both are treated in different ways.
text: Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases.
text: Around 80 to 85 out of 100 lung cancers (around 80 - 85%) in the UK are non small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.
text: In lung cancer, immunotherapy has only been approved for most types of non-small cell lung cancer (NSCLC) and will likely soon be approved for small cell lung cancer.
text: This treatment is used for patients with non-small cell lung cancer (NSCLC) who no longer respond after chemotherapy and EGFR or ALK targeted therapy (if their tumor has those genetic mutations).
text: This treatment is used for patients with non-small cell lung cancer (NSCLC) who no longer respond after chemotherapy and EGFR or ALK targeted therapy (if their tumor has those genetic mutations).
text: It’s also being studied in a number of other tumors, including non-small cell lung cancer (NSCLC) and small cell lung cancers (SCLC).
text: Non-small-cell lung cancer (NSCLC) tends to grow more slowly and takes longer to spread beyond the lung.
text: The staging system described here is the system used for non-small cell lung cancer (NSCLC). including lung adenocarcinoma, squamous cell lung cancer, and large cell lung cancer.
text: There are two types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
text: ROS1 rearrangements occur in approximately 1-2% of patients with non-small cell lung cancer (NSCLC).
text: Drugs that target these checkpoints (called checkpoint inhibitors) can be used to treat some people with non-small cell lung cancer (NSCLC) .
text: There are two main kinds of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC) account for about 85% to 90% of lung cancer cases.
text: There are two major types of lung cancer, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
text: Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.
text: Non-small cell lung cancers (NSCLC) may grow slowly over a period of time before symptoms develop.
text: The SEER database tracks 5-year relative survival rates for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) in the United States, based on how far the cancer has spread.
text: The two main types are small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: A randomized placebo-controlled trial of erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy.
text: A randomized, multicenter, phase III study of cetuximab in combination with cisplatin/vinorelbine (CV) versus CV alone in the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC).
text: The treatment options for non-small cell lung cancer (NSCLC) are based mainly on the stage (extent) of the cancer, but other factors, such as a person’s overall health and lung function, as well as certain traits of the cancer itself, are also important.
text: Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer.
text: Characterised by uncontrolled growth of abnormal cells in the lung, the two main forms of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
text: In lung cancer there are two main types, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
text: There are two major types of lung cancer: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC).
text: Targeted agents are beginning to permit the design of more rational treatment regimens for non-small cell lung cancer (NSCLC), which comprises about 80% to 85% of all lung cancers.
text: It may be possible to cure some types of non-small cell lung cancer (NSCLC) with surgery, if it’s at an early-stage and hasn’t spread.
text: Non-small cell lung cancer (NSCLC) that has not spread is usually treated with surgery first.
text: Doctors once thought non-small-cell lung cancer (NSCLC) was one disease.
text: Lung cancers are divided into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer.
text: In non-small cell lung cancer (NSCLC), the most important prognostic factor is the stage (extent of spread) of the tumor at the time of diagnosis.
text: Researchers are trying to identify alternative strategies to treat non-small cell lung cancer (NSCLC).
text: Lung cancer includes two main types: non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC).
text: For clinical and treatment purposes, however, most oncologists tend to classify lung carcinomas into two major groups, namely small cell carcinoma (SCLC) and non-small cell lung cancer (NSCLC).
text: In 2019, the FDA approved pembrolizumab for the first-line treatment of people with stage III non-small cell lung cancer (NSCLC) who are not candidates for surgical resection or definitive chemoradiation or metastatic NSCLC.
text: Depending on the stage of the non-small cell lung cancer (NSCLC) and other factors, radiation therapy might be used:
text: Non–small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers and is divided into adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
text: For the purpose of treatment and prognosis, lung cancer is divided into 2 categories: small cell lung cancer (SCLC) and non–small cell lung cancer (NSCLC).
text: There are two major types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and each one has several subtypes.
text: Not all people with non-small cell lung cancer (NSCLC) will need chemo, but depending on the cancer's stage and other factors, chemo may be recommended in different situations:
text: Because he was too weak and frail for surgery, his treatment options were more limited; as many as a third of people with early non-small cell lung cancer (NSCLC) find themselves in this challenging position, too.
text: Surgery is still the preferred treatment for non-small cell lung cancer (NSCLC), while small cell type lung cancer so easily spreads due to the fragility of the cancer cells that surgery is rarely considered.
text: There are 2 main classifications of lung cancer: small cell lung cancer and non-small cell lung cancer (NSCLC).
text: Non-small cell lung cancer (NSCLC) comprises approximately 85-90% of all known lung cancers cases.